E. Sahin Et Al. , "The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20, 2020
Sahin, E. Et Al. 2020. The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20 .
Sahin, E., Yonal-Hindilerden, I., Hindilerden, F., Daglar-Aday, A., & Nalcaci, M., (2020). The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20.
Sahin, Ezgi Et Al. "The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20, 2020
Sahin, Ezgi Et Al. "The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20, 2020
Sahin, E. Et Al. (2020) . "The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20.
@article{article, author={Ezgi ŞAHİN Et Al. }, title={The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2020}